ENDP Endo International plc

7.12
-0.03  -0%
Previous Close 7.15
Open 7.22
Price To Book -3.21
Market Cap 1588496279
Shares 223,103,410
Volume 2,615,470
Short Ratio
Av. Daily Volume 3,354,329

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Advisory Committee Meeting March 14, 2017 voted 18 to eight that the benefits of reformulated OPANA ER no longer outweigh its risks.
OPANA ER
Management of pain
Approved October 26, 2015.
BEMA Buprenorphine
Management of pain severe enough to require daily, around-the-clock, long-term opioid treatment for which alternative treatment options are inadequate
CRL issued May 30 2013. Approved March 6 2014.
AVEED (testosterone undecanoate) intramuscular injection
Men diagnosed with hypogonadism
BLA filing 2H 2019.
XIAFLEX (collagenase clostridium histolyticum) - RELEASE
Edematous fibrosclerotic panniculopathy (“cellulite”)

Latest News

  1. Endo to Announce First-Quarter 2019 Financial Results
  2. When Will Endo International plc (NASDAQ:ENDP) Breakeven?
  3. See what the IHS Markit Score report has to say about Endo International PLC.
  4. Endo Begins Shipment of Authorized Generic Version of PROVENTIL® (albuterol sulfate) HFA Inhalation Aerosol in the United States
  5. Drug companies that benefit from the war on opioid addiction
  6. Why Is Endo (ENDP) Down 26.9% Since Last Earnings Report?
  7. Endo International plc Announces Early Tender Results of its Previously Announced Cash Tender Offers and Consent Solicitations for up to $1.5 billion Aggregate Purchase Price of its Outstanding Senior Notes
  8. Endo International: Wall Street Ratings Not Very Favorable?
  9. Catalyst (CPRX) Reports Wider Q4 Loss, Focuses on Firdapse
  10. Endo Announces Publication Of Collagenase Clostridium Histolyticum (CCH) Phase 2 Data In Dermatologic Surgery
  11. BioDelivery (BDSI) Q4 Earnings In Line, Sales Beat, Stock Up
  12. Endo International plc Announces an Upsizing of its Cash Tender Offers and Consent Solicitations
  13. Endo International plc Announces Pricing of Private Offering Of Senior Secured Notes
  14. Endo Finance Co. -- Moody's downgrades Endo's secured debt to Ba3, unsecured notes to Caa1; B2 CFR affirmed
  15. Insys Plunges on Auditor's Concern About Insufficient Funds
  16. Endo International plc Announces Debt Refinancing Transactions, Including Cash Tender Offers and Consent Solicitations for up to $1.0 billion Aggregate Purchase Price of its Outstanding Senior Notes
  17. Endo International plc Announces Proposed Private Offering Of Senior Secured Notes
  18. Is Endo International (ENDP) a Great Stock for Value Investors?
  19. Opioid litigation concerns weigh on pharmaceutical loan borrowers